Marcus Lindner

Papers

1

Total Citations

2

H-Index

1

About

Dr. Marcus Lindner is a urologic oncologist whose research focuses on improving surgical outcomes for prostate cancer patients, particularly through the optimization of robotic-assisted laparoscopic techniques. His work centers on refining extended pelvic lymph node dissection (ePLND), a critical procedure for accurate cancer staging, and on developing practical tools to better assess patient risk. A key contribution is his validation of a questionnaire-based comorbidity index, studied in a cohort of over 5,000 consecutive patients undergoing radical prostatectomy. This work aims to create an easily applicable method for predicting surgical risk and outcomes, moving beyond traditional metrics. While his most cited paper has garnered 2 citations, it represents a foundational step in a larger body of work dedicated to enhancing the precision and safety of robotic prostate cancer surgery. Dr. Lindner’s research is directly relevant to urologists and surgeons seeking to refine patient selection and improve the quality of life for men facing prostate cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
PD40-07 VALIDATION OF AN EASILY APPLICABLE QUESTIONNAIRE-SUITED COMORBIDITY INDEX IN 5050 CONSECUTIVE PATIENTS UNDERGOING RADICAL PROSTATECTOMY
2 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 8

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago